The Global computational biology market is
expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%,
according to a new study by Grand View Research, Inc. Steady increase in
the usage & application of computational biology for bioinformatics R&D
programs designed for sequencing genomes to better understand biological
systems and increasing number of clinical studies in pharmacogenomics and
pharmacokinetics for novel drug discovery studies are expected to drive
computational biology demand over the next six years.
Computational genomics
for cellular and biological simulation applications dominated the market in
2013, accounting for over 47% of global revenue. Key factors driving demand for
these applications include the growth of drug designing, disease modeling and
personalized medicine applications and the growing usage of computational
biology for functional and structural genomics, epigenomics and metagenomics
for the analysis of protein transcription, protein-protein interactions, gene
sequencing and expression and 3-dimensional protein structure analysis.
Browse full report by Grand View
Research :
Further key findings from the study suggest:
·
North America was the largest regional
market, accounting for 58.0% of the global revenue in 2013. Its large share is
majorly attributed to the growing research investments and initiatives for
development of drug discovery, disease modeling technologies and innovations in
biological computation methods. It is expected that Asia Pacific will witness
the fastest growth in the market, at an estimated CAGR of 28.0% owing to the
increasing expenditure in clinical studies for pharmacokinetics and
pharmacogenomics.
·
The application of computational biology in
proteomics for cellular simulation is expected to grow at the fastest CAGR of
over 22% owing to the shift in sequencing studies towards further analysis of
the nature of various biological proteins as a part of development of
personalized medicine.
·
Drug discovery and disease modelling
applications dominated the market, accounting for 58.0% of global revenue in
2013. This large share is attributed by the extensive drug development
pipelines present for a number of global branded and generic drug manufacturing
firms such as Sanofi, Novo Nordisk and Eli Lilly.
·
Computational Biology databases dominated
the tools segment and accounted for 44.5% of the market revenue in 2013, owing
to extensive genomic database usage for warehousing and data mining of
biological and sequential data generated from genomic and proteomic studies.
Consequentially, the software and services for the analysis of biological data
is expected to witness the fastest CAGR of over 21.0%.
·
Key players of this market include
Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has
segmented the computational biology market on the basis of applications, tools,
services, end users and region:
Computational Biology Application Outlook
·
Cellular & Biological Simulation
o Computational Genomics
o Computational Proteomics
o Pharmacogenomics
o Others (Transcriptomics/Metabolomics)
·
Drug Discovery and Disease Modelling
o Target Identification
o Target Validation
o Lead Discovery
o Lead Optimization
·
Preclinical Drug Development
o Pharmacokinetics
o Pharmacodynamics
·
Clinical trials
o Phase I
o Phase II
o Phase III
·
Human Body Simulation Software
Computational Biology Tools Outlook
·
Databases
·
Infrastructure (Hardware)
·
Analysis Software & Services
Computational Biology Services Outlook
·
In-house
·
Contract
Computational Biology End User Outlook
·
Academics
·
Industry
·
Commercial
Computational Biology Regional Outlook
·
North America
·
Europe
·
Asia Pacific
·
RoW
Access
press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-computational-biology-market
About
Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
more information: http://www.grandviewresearch.com
No comments:
Post a Comment